A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel

Summary

This is a 2 week Phase 1 study of SB204 (NVN1000 Gel) in healthy adult volunteers with elevated Propionibacterium acnes (P. acnes) counts. Subjects will apply NVN1000 4% Gel or Vehicle Gel twice daily to their face. Assessments will include cutaneous tolerability, safety, and P. acnes counts.

Timeline

Start

2013-04

Primary completion

2013-06

Completion

2013-06

Drugs

Indications